Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.80 |
| ▸ | MAPT | P10636 | 1/20 | 0.80 |
| ▸ | CES2 | O00748 | 4/20 | 0.68 |
| ▸ | CES1 | P23141 | 4/20 | 0.68 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.65 |
| ▸ | PPARG | P37231 | 7/20 | 0.65 |
| ▸ | PPARD | Q03181 | 7/20 | 0.65 |
| ▸ | PPARA | Q07869 | 7/20 | 0.65 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.65 |
| ▸ | TSHR | P16473 | 5/20 | 0.65 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.65 |
| ▸ | TLR2 | O60603 | 2/20 | 0.65 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.65 |
| ▸ | FABP4 | P15090 | 2/20 | 0.65 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.65 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.65 |
| ▸ | MEN1 | O00255 | 1/20 | 0.65 |
| ▸ | ESR1 | P03372 | 1/20 | 0.65 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21044717 | 1.00 | KMT2A (0.80) | KMT2AMAPTCES2CES1GPR84 | |
| SCHEMBL21044654 | 1.00 | KMT2A (0.80) | KMT2AMAPTCES2CES1GPR84 | |
| SCHEMBL21044649 | 1.00 | KMT2A (0.80) | KMT2AMAPTCES2CES1GPR84 | |
| SCHEMBL21044663 | 1.00 | KMT2A (0.80) | KMT2AMAPTCES2CES1GPR84 | |
| SCHEMBL23530128 | 1.00 | KMT2A (0.80) | KMT2AMAPTCES2CES1GPR84 | |
| SCHEMBL23530133 | 1.00 | KMT2A (0.80) | KMT2AMAPTCES2CES1GPR84 | |
| SCHEMBL23397936 | 1.00 | KMT2A (0.80) | KMT2AMAPTCES2CES1GPR84 | |
| SCHEMBL23748450 | 1.00 | KMT2A (0.80) | KMT2AMAPTCES2CES1GPR84 | |
| SCHEMBL23530132 | 1.00 | KMT2A (0.80) | KMT2AMAPTCES2CES1GPR84 | |
| SCHEMBL21044697 | 1.00 | KMT2A (0.80) | KMT2AMAPTCES2CES1GPR84 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 147 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118496710-A | High-hardness high-flexibility silk-screen printing ink containing composite prepolymer and preparation method thereof | 深圳市丽冠卓宏科技有限公司 | 2024-08-16 | — | — | CN | claimed |
| CN-115161630-B | Pickling passivation treatment process of seamless stainless steel tube | 华迪钢业集团有限公司 | 2023-07-21 | — | — | CN | claimed |
| CN-115161630-A | Pickling and passivating treatment process for seamless stainless steel pipe | 华迪钢业集团有限公司 | 2022-10-11 | — | — | CN | claimed |
| CN-112584900-A | Arginase inhibitors and methods of use thereof | 阿斯利康(瑞典)有限公司 | 2021-03-30 | — | — | CN | claimed |
| EP-3507280-A2 | COALESCING AGENT DERIVED FROM DIOXOLANE DERIVATIVES | PTT Global Chemical Public Company Limited (TH) | 2019-07-10 | — | — | EP | claimed |
| CN-107417705-B | Imidazo [2,1-b] benzothiazole compound and its synthetic method | 湘潭大学 | 2019-07-02 | — | — | CN | claimed |
| CN-108069843-A | The method for preparing cyclohexanone and derivative | 国际香料和香精公司 | 2018-05-25 | — | — | CN | claimed |
| CN-102617390-B | Preparation method of epsilon-N-lauroyl lysine | ZHANGJIAGANG HUACHANG PHARMACEUTICAL CO LTD | 2013-06-05 | — | — | CN | claimed |
| US-6867331-B2 | Method for producing deoxybenzoins | BASF AKTIENGESELLSCHAFT (DE) | 2005-03-15 | — | — | US | claimed |
| US-20050004400-A1 | METHOD FOR PRODUCING DEOXYBENZOINS | BASF AKTIENGESELLSCHAFT (DE) | 2005-01-06 | — | — | US | claimed |
| CN-1551908-A | UV cured UV blocking compositions and methods for making and using the same | �¿�ר������˾ | 2004-12-01 | — | — | CN | claimed |
| EP-1109799-B1 | 4,5-DIARYL-3(2H)-FURANONE DERIVATIVES AS CYCLOOXYGENASE-2 INHIBITORS | PACIFIC CORP (KR) | 2003-12-17 | — | — | EP | claimed |
| EP-0508469-B1 | 3,4,N-Trisubstituted-4,5-dihydro-1H-pyrazole-1-carboxamides and their use as insecticides | DOWELANCO (US) | 1999-03-03 | — | — | EP | claimed |
| US-5493024-A | 1,2-DIARYL-2-PROPEN-1-ONE CHEMICAL INTERMEDIATE COMPOUND | DOWELANCO (US) | 1996-02-20 | — | — | US | claimed |
| US-5338856-A | 3,4-N,trisubstituted-4,5-dihydro-1H-pyrazole-1-carboxamides and their use as insecticides | DOWELANCO (US) | 1994-08-16 | — | — | US | claimed |
| EP-0508469-A1 | 3,4,N-Trisubstituted-4,5-dihydro-1H-pyrazole-1-carboxamides and their use as insecticides | DOWELANCO (US) | 1992-10-14 | — | — | EP | claimed |
| US-20250368596-A1 | PROCESS FOR THE DECARBOXYLATIVE KETONIZATION OF C2-C8 CARBOXYLIC ACIDS, DERIVATIVES OR MIXTURES THEREOF | SPECIALTY OPERATIONS FRANCE (FR) | 2025-12-04 | — | — | US | disclosed |
| EP-4540214-A1 | PROCESS FOR THE DECARBOXYLATIVE KETONIZATION OF C2-C8 CARBOXYLIC ACIDS, DERIVATIVES OR MIXTURES THEREOF | SPECIALTY OPERATIONS FRANCE (FR) | 2025-04-23 | — | — | EP | disclosed |
| US-4016223-A | Prostaglandin dehydrogenase inhibiting agents | NELSON RESEARCH & DEVELOPMENT COMPANY (US) | 1977-04-05 | — | — | US | disclosed |
| US-3976697-A | Preparation of tertiary amines | TEXACO INC. (US) | 1976-08-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050004400-A1 | METHOD FOR PRODUCING DEOXYBENZOINS | DHPS, KMO, ALKBH3 | KMT2A 1012/4885MAPT 4307/4885CES2 1094/4885 |
| US-20250368596-A1 | PROCESS FOR THE DECARBOXYLATIVE KETONIZATION OF C2-C8 CARBOXYLIC ACIDS, DERIVATIVES OR MIXTURES THEREOF | MCCC2, PCCA, PC | KMT2A 1357/4885MAPT 2147/4885CES2 537/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.